Hyaluronidase inhibitor sHA2.75 alleviates ischemia-reperfusion-induced acute kidney injury
Hyaluronidases (HAases) are enzymes that degrade hyaluronic acid (HA) in the animal kingdom. The HAases-HA system is crucial for HA homeostasis and plays a significant role in biological processes and extracellular matrix (ECM)-related pathophysiological conditions. This study aims to explore the role of inhibiting the HAases-HA system in acute kidney injury (AKI). We selected the potent inhibitor "sHA2.75" to inhibit HAase activity through mixed inhibitory mechanisms. The ischemia-reperfusion mouse model was established using male BALB/c mice (7-9 weeks old), and animals were subjected to subcapsular injection with 50 mg/kg sHA2.75 twice a week to evaluate the effects of sHA2.75 on AKI on day 1, 5 and 14 after ischemia-reperfusion or sham procedure. Blood and tissue samples were collected for immunohistochemistry, biochemical, and quantitative analyses. sHA2.75 significantly reduced blood urea nitrogen (BUN) and serum creatinine levels in AKI mouse models. Expression of kidney injury-related genes such as Kidney injury molecule-1 (KIM-1), Neutrophil Gelatinase-Associated Lipocalin (NGAL), endothelial nitric oxide synthase (eNOS), type I collagen (Col1), type III collagen (Col3), alpha-smooth muscle actin (α-SMA) showed significant downregulation in mouse kidney tissues after sHA2.75 treatment. Moreover, sHA2.75 treatment led to decreased plasma levels of Interleukin-6 (IL-6) proteins and reduced mRNA levels in renal tissues of AKI mice. Inhibitor sHA2.75 administration in the AKI mouse model downregulated kidney injury-related biomarkers and immune-specific genes, thereby alleviating AKI in vivo. These findings suggest the potential use of HAase inhibitors for treating ischemic reperfusion-induced kidney injury.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
---|---|
Enthalten in: |
Cell cycle (Georgetown, Tex.) - 23(2024), 3 vom: 22. Feb., Seite 248-261 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhang, Yang [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 26.04.2024 Date Revised 26.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/15384101.2024.2309019 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM37015715X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM37015715X | ||
003 | DE-627 | ||
005 | 20240426234008.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240326s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/15384101.2024.2309019 |2 doi | |
028 | 5 | 2 | |a pubmed24n1388.xml |
035 | |a (DE-627)NLM37015715X | ||
035 | |a (NLM)38526145 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhang, Yang |e verfasserin |4 aut | |
245 | 1 | 0 | |a Hyaluronidase inhibitor sHA2.75 alleviates ischemia-reperfusion-induced acute kidney injury |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.04.2024 | ||
500 | |a Date Revised 26.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Hyaluronidases (HAases) are enzymes that degrade hyaluronic acid (HA) in the animal kingdom. The HAases-HA system is crucial for HA homeostasis and plays a significant role in biological processes and extracellular matrix (ECM)-related pathophysiological conditions. This study aims to explore the role of inhibiting the HAases-HA system in acute kidney injury (AKI). We selected the potent inhibitor "sHA2.75" to inhibit HAase activity through mixed inhibitory mechanisms. The ischemia-reperfusion mouse model was established using male BALB/c mice (7-9 weeks old), and animals were subjected to subcapsular injection with 50 mg/kg sHA2.75 twice a week to evaluate the effects of sHA2.75 on AKI on day 1, 5 and 14 after ischemia-reperfusion or sham procedure. Blood and tissue samples were collected for immunohistochemistry, biochemical, and quantitative analyses. sHA2.75 significantly reduced blood urea nitrogen (BUN) and serum creatinine levels in AKI mouse models. Expression of kidney injury-related genes such as Kidney injury molecule-1 (KIM-1), Neutrophil Gelatinase-Associated Lipocalin (NGAL), endothelial nitric oxide synthase (eNOS), type I collagen (Col1), type III collagen (Col3), alpha-smooth muscle actin (α-SMA) showed significant downregulation in mouse kidney tissues after sHA2.75 treatment. Moreover, sHA2.75 treatment led to decreased plasma levels of Interleukin-6 (IL-6) proteins and reduced mRNA levels in renal tissues of AKI mice. Inhibitor sHA2.75 administration in the AKI mouse model downregulated kidney injury-related biomarkers and immune-specific genes, thereby alleviating AKI in vivo. These findings suggest the potential use of HAase inhibitors for treating ischemic reperfusion-induced kidney injury | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Acute kidney injury (AKI) | |
650 | 4 | |a hyaluronidase inhibitor | |
650 | 4 | |a ischemic reperfusion injury (IRI) model | |
650 | 7 | |a Hyaluronoglucosaminidase |2 NLM | |
650 | 7 | |a EC 3.2.1.35 |2 NLM | |
650 | 7 | |a Hyaluronic Acid |2 NLM | |
650 | 7 | |a 9004-61-9 |2 NLM | |
650 | 7 | |a Creatinine |2 NLM | |
650 | 7 | |a AYI8EX34EU |2 NLM | |
650 | 7 | |a Lipocalin-2 |2 NLM | |
700 | 1 | |a Zhao, Huajiang |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Jing |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cell cycle (Georgetown, Tex.) |d 2002 |g 23(2024), 3 vom: 22. Feb., Seite 248-261 |w (DE-627)NLM122165837 |x 1551-4005 |7 nnns |
773 | 1 | 8 | |g volume:23 |g year:2024 |g number:3 |g day:22 |g month:02 |g pages:248-261 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/15384101.2024.2309019 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 23 |j 2024 |e 3 |b 22 |c 02 |h 248-261 |